AMVUTTRA™ (vutrisiran)
www.amvuttra.com
www.amvuttra.com
AmvuttraTM (vutrisiran) is indicated for the treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adults.
AmvuttraTM (vutrisiran) is indicated for the treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adults.